-
Sep 2009
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells.
Proc Natl Acad Sci U S AFontenot D, He H, Hanabuchi S, Nehete PN, Zhang M, Chang M, Nehete B, Wang YH, Wang YH, Ma ZM, Lee HC, Ziegler SF, Courtney AN, Miller CJ, Sun SC, Liu YJ, Sastry KJ -
Sep 2009
The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.
J ImmunolJames EA, Moustakas AK, Bui J, Nouv R, Papadopoulos GK, Kwok WW -
Sep 2009
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. -
Sep 2009
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.
J Leukoc BiolBollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT -
Sep 2009
Thymic stromal lymphopoietin and the pathophysiology of atopic disease.
Expert Rev Clin ImmunolMiazgowicz MM, Headley MB, Larson RP, Ziegler SF -
Sep 2009
Changes in autoreactive T cell avidity during type 1 diabetes development.
Clin ImmunolStandifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT -
Aug 2009
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.
J ImmunolBollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT -
Aug 2009
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.
BloodEttinger RA, James EA, Kwok WW, Thompson AR, Pratt KP -
Aug 2009
Remodeling rodent models to mimic human type 1 diabetes.
Eur J Immunolvon Herrath M, Nepom GT -
Aug 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Clin ImmunolHerold KC, Gitelman S, Greenbaum CJ, Puck J, Hagopian WA, Gottlieb PA, Sayre PH, Bianchine PJ, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, Immune Tolerance Network ITN007AI Study Group. -
Jul 2009
Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
PLoS OneFleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM -
Jul 2009
Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms.
J ImmunolGebe JA, Yue BB, Unrath KA, Falk BA, Nepom GT -
Jul 2009
The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis.
J Clin Endocrinol MetabMa X, Becker D, Arena VC, Vicini P, Greenbaum CJ -
Jun 2009
H5N1 strain-specific hemagglutinin CD4+ T cell epitopes restricted by HLA DR4.
VaccineYang J, Gebe JA, Huston L, James EA, Tan V, Yue BB, Nepom GT, Kwok WW -
Jun 2009
Narcolepsy is strongly associated with the T-cell receptor alpha locus.
Nat GenetHallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, Mayer G, Plazzi G, Nevsimalova S, Bourgin P, Hong SC, Honda Y, Honda M, Högl B, Longstreth WT Jr, Montplaisir J, Kemlink D, Einen M, Chen J, Musone SL, Akana M, Miyagawa T, Duan J, Desautels A, Erhardt C, Hesla PE, Poli F, Frauscher B, Jeong JH, Lee SP, Ton TG, Kvale M, Kolesar L, Dobrovolná M, Nepom GT, Salomon D, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Young T, Peppard P, Tokunaga K, Kwok PY, Risch N, Mignot E
